You are about to leave an AbbVie Canada site, a Web site maintained by AbbVie Corporation.

This link is provided for your convenience only. AbbVie Corporation takes no responsibility for the content of any Web site maintained by any third party and makes no representation as to the accuracy or completeness of any information contained on this or any subsequent link.

Do you wish to leave this site?

Yes No

You are here

Complete-AS

Canadian HUMIRA Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis.

    Status Recruiting
    Related Conditions
    Spondylarthrite ankylosante

Enrollment Details

Phases: 

  • I
  • II
  • III
  • IV
Study Type:  Observational

This is a type IV phase trial.

Protocol ID
P12-672

Brief summary

Top

The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.

Participant Attributes :
  • Male and Female
  • Ages 18 Years to 99 Years

Canada: 83

0
Brampton, ON
1
Ottawa, ON
2
Burlington, ON
3
Burlington, ON
4
Calgary, AB
5
Cranbrook, BC
6
Fredericton, NB
7
Fredericton, NB
8
Hamilton, ON
9
Hamilton, ON
10
Hamilton, ON
11
Kamloops, BC
12
Kitchener, ON
13
Laval, QC
14
Milton, ON
15
Mississauga, ON
16
Mississauga, ON
17
Mississauga, ON
18
Montreal, QC
19
Montreal, QC
20
Montreal, QC
21
Ottawa, ON
22
Ottawa, ON
23
Montreal, QC
24
Owen Sound, ON
25
Penticton, BC
26
Prince George, BC
27
Quebec, QC
28
Rimouski, QC
29
St. Catharines, ON
30
St. John's, NL
31
Toronto, ON
32
Toronto, ON
33
Toronto, ON
34
Toronto, ON
35
Trois-Rivières, QC
36
Vancouver, BC
37
Winnipeg, MB
38
Barrie, ON
39
Brampton, ON
40
Burnaby, BC
41
Calgary, AB
42
Calgary, AB
43
Calgary, AB
44
Calgary, AB
45
Edmonton, AB
46
Gatineau, QC
47
Greenfield Park, QC
48
Guelph, ON
49
Halifax, NS
50
Halifax, NS
51
Hamilton, ON
52
Kamloops, BC
53
West Kelowna, BC
54
Lethbridge, AB
55
London, ON
56
London, ON
57
Lunenburg, NS
58
Mississauga, ON
59
Westmount, QC
60
Montreal, QC
61
Montreal, QC
62
Montreal, QC
63
Nanaimo, BC
64
New Westminster, BC
65
Newmarket, ON
66
Newmarket, ON
67
Ottawa, ON
68
Ottawa, ON
69
Penticton, BC
70
Quebec, QC
71
Quispamsis, NB
72
Richmond, BC
73
Sarnia, ON
74
Sherbrooke, QC
75
Saint-Eustache, QC
76
St. John's, NL
77
Thunder Bay, ON
78
Toronto, ON
79
Toronto, ON
80
Toronto, ON
81
Toronto, ON
82
West Vancouver, BC
Would you like to know more about this trial?

Study Design

  • The general design that describes the strategy for identifying and following up with participants during observational studies.
    ?

    Observational Model

    Cohort

  • The relationship between the observation period and the time of patient enrollment. Time perspective can be prospective: looking forward using periodic observations usually collected following patient enrollment, or retrospective: looking back using observations usually collected prior to patient selection and enrollment.
    ?

    Time Perspective

    Prospective

    • Adult >= 18 years old;
    • Has provided written informed consent allowing the use of their data for the study and providing permission for contact by the study personnel;
    • Active Ankylosing Spondylitis as per the judgment of the treating physician;
    • Inadequate response or non tolerant to current NSAID (Nonsteroidal Anti-Inflammatory Drug) or DMARD (Disease-Modifying Anti Rheumatic Drug) based treatment for AS
    • Currently participating in another prospective study including controlled clinical trials and observational studies;
    • Patient cannot or will not sign informed consent;
    • Stable disease with adequate tolerance and response to current treatment and no change in treatment is indicated;
    • Previous treatment with anti-TNF (Tumor Necrosis Factor) or other biologic agent;
    • Presence of other condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of AS

More on this trial

Clinical Trials.gov